tiprankstipranks
Protect Pharmaceutical Corporation (PRTT)
OTHER OTC:PRTT
US Market
Holding PRTT?
Track your performance easily

Protect Pharmaceutical (PRTT) Income Statement

14 Followers

Protect Pharmaceutical Income Statement

Last quarter (Q ), Protect Pharmaceutical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Protect Pharmaceutical's net income was $-4.43K. See Protect Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 17Dec 16Dec 15Dec 14Dec 13
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
----$ 0.00$ 0.00
Gross Profit
----$ 0.00$ 0.00
Operating Expense
$ 707.00$ 115.40K$ 41.71K$ 30.03K$ 30.85K$ 23.94K
Operating Income
$ -707.00$ -115.40K$ -41.71K$ -30.03K$ -30.85K$ -23.94K
Net Non Operating Interest Income Expense
$ -14.33K$ -7.21K$ 0.00---
Other Income Expense
---$ -605.44K$ 488.99K-
Pretax Income
$ -15.04K$ -122.61K$ -41.71K$ -635.46K$ 458.14K$ -23.94K
Tax Provision
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -15.04K$ -122.61K$ -41.71K$ -635.46K$ 458.14K$ -23.94K
Basic EPS
$ >-0.01$ -0.11$ -0.04$ -1.44$ 8.48$ 0.00
Diluted EPS
$ >-0.01$ -0.11$ -0.04$ -1.44$ 8.48$ 0.00
Basic Average Shares
$ 4.45M$ 1.11M$ 1.11M$ 442.17K$ 54.05K$ 44.57K
Diluted Average Shares
$ 5.31M$ 1.20M$ 1.11M$ 442.17K$ 89.46K$ 44.57K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 707.00$ 115.40K$ 41.71K$ 30.03K$ 30.85K$ 23.94K
Net Income From Continuing And Discontinued Operation
$ -15.04K$ -122.61K$ -41.71K$ -635.46K$ 458.14K$ -23.94K
Normalized Income
$ -15.04K$ -122.61K$ -41.71K$ -30.03K$ -30.85K$ -23.94K
Interest Expense
$ 14.33K$ 7.21K$ 0.00---
EBIT
$ -707.00$ -115.40K$ -41.71K$ -30.03K$ -30.85K$ -23.94K
EBITDA
$ -707.00$ -115.40K$ -41.71K$ -30.03K$ -30.85K$ -23.94K
Currency in USD

Protect Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis